$3.640
-0.020 (-0.55%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RXRX Prediction & Forecast by Similar Chart Analysis
Alphio's RXRX stock price prediction model matches the current Recursion Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.55 (-0.75%). The 1-week path is $3.55 (-0.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Recursion Pharmaceuticals Inc Stock?
Recursion Pharmaceuticals Inc (RXRX) is a good buy right now, especially considering the recent surge in milestone payments from its collaboration with Sanofi, which could exceed $300 million. The current price of $3.465 is significantly below the analyst price target of $5.50, indicating a potential upside of 58.6%. Additionally, the RSI is at 35.676, suggesting that the stock is oversold and may be due for a rebound. However, the main risk is the recent 20.53% decline over the last five days, indicating volatility.
RXRX stock price ended at $3.64 on Wednesday, after losing -0.55%
Recursion Pharmaceuticals Inc (RXRX) last closed at $3.58, losing -1.65%. These facts feed the 1-day and 1-week RXRX price prediction above.
Forecast Drivers
Recursion Pharmaceuticals Inc (RXRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RXRX, ranked by similarity.
Seasonality analysis for RXRX
Historically the probability of a positive October return for RXRX is 6.45%. January offers the highest probability of a positive month at 70.49%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RXRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $4.81 | $6.43 | $7.75 | +79.71% |
| Nov 2026 | $3.30 | $4.90 | $6.52 | +36.95% |
| Dec 2026 | $5.32 | $5.57 | $6.14 | +55.60% |
In 2026, Recursion Pharmaceuticals Inc (RXRX) is projected to range from $3.30 to $7.75.
Recursion Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Recursion Pharmaceuticals Inc is projected to average $6.43, with a low of $4.81 and high of $7.75.
In Nov 2026, Recursion Pharmaceuticals Inc is projected to average $4.90, with a low of $3.30 and high of $6.52.
In Dec 2026, Recursion Pharmaceuticals Inc is projected to average $5.57, with a low of $5.32 and high of $6.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.